Rectify is developing disease-modifying precision therapies that restore ABC transporter function to address the underlying cause of serious genetic diseases. The company’s pipeline spans multiple therapeutic areas. Rectify was founded, seeded, and launched by Atlas Venture and is headquartered in Cambridge, Massachusetts.
Rectify Pharma Address
400 Technology Square Cambridge, MA
Rectify Pharma Email
Past Companies
Rectify PharmaChief Development Officer
Clover BiopharmaceuticalsChief Portfolio Officer
Voyager Therapeutics, Inc.Vice President, Head of Program Leadership and Portfolio Management